Mkts

Kiniksa Pharmaceuticals International, plc

NASDAQ: KNSA
$88.34-7.78 (-8.09%)
As of Nov 5, 4:00 PM ET

Key statistics

Day range
87.3096.99
52-week range
37.0298.48
Today
Open95.49
Previous close88.34
Volume—
Valuation
Market cap7.11B
P/E ratio88.12×
EPS (TTM)0.98
Income & risk
Dividend / yield—
Beta0.10
Avg volume682.7K
Discussion

KNSA News

Stories mentioning KNSA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue214,266202,127180,855156,797137,785122,536112,214108,631
Cost of Goods Sold20,79620,94520,25718,60317,86817,89620,10912,322
Gross Profit193,470181,182160,598138,194119,917104,64092,10596,309
Operating Expenses
Research & Development27,47534,60924,16618,75319,32535,21526,05724,017
Sales General & Admin61,15156,77549,10446,86343,53040,53546,39942,395
Total Operating Expenses
Operating Income (Loss)29,26719,76824,02120,16013,272(19,299)(9,658)(117.00)
Interest Income
Interest Expense
Other Expense
Pretax Income32,68123,26927,15722,87715,565(16,979)(7,201)2,304
Tax Provision10,0899,0708,7225,0457,026(8,091)5,4926,212
Net Income (Loss)22,59214,19918,43517,8328,539(8,888)(12,693)(3,908)
Earnings Per Share (Basic)0.300.190.250.240.12(0.12)(0.18)(0.06)
Earnings Per Share (Diluted)0.270.180.230.230.11(0.12)(0.18)(0.06)
Weighted Average Shares Outstanding (Basic)76,51774,20174,71573,43972,64771,42471,72771,005
Weighted Average Shares Outstanding (Diluted)82,41078,97980,03577,94276,14671,42471,72771,005

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About KNSA

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) is a stock listed on the Nasdaq Stock Market under the ticker symbol KNSA. It last traded at $88.34 (Nov 5, 2026, 4:00 PM ET), down 8.1% on the day. That gives Kiniksa Pharmaceuticals International a market capitalisation of $7.1B and a price-to-earnings ratio of 88.1.

Over the past 52 weeks KNSA has traded between $37.02 and $98.48.

Revenue for the quarter ended Mar 31, 2026 was $214.3M; net income $22.6M. Revenue was up 55.5% from $137.8M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$214.3M$22.6M10.5%
Dec 31, 2025$202.1M$14.2M7.0%
Sep 30, 2025$180.9M$18.4M10.2%
Jun 30, 2025$156.8M$17.8M11.4%

From Kiniksa Pharmaceuticals International’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…